Phase 2a Trial of Alpibectir Plus Ethionamide for Tuberculosis Meningitis
Clinical trial NCT07350174 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07350174
- Sponsor
- BioVersys AG
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-30
- Primary completion
- 2028-03-30
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.